Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Evotec AG : Notification and public disclosure of transactions by persons

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/18/2017 | 02:15pm CET


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

18.09.2017 / 14:12
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Werner
Last name(s): Lanthaler

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Evotec AG

b) LEI
529900F9KI6OYITO9B12 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE0005664809

b) Nature of the transaction
Purchase of shares by exercising stock options
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)
Price(s) Volume(s)
17.7711 EUR 1064577.75 EUR

d) Aggregated information
Price Aggregated volume
17.7711 EUR 1064577.75 EUR

e) Date of the transaction
2017-09-15; UTC+2

f) Place of the transaction
Outside a trading venue



18.09.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Internet: www.evotec.com

 
End of News DGAP News Service

37751  18.09.2017 


© EQS 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EVOTEC AG
12/13 EVOTEC : Academic Bridge LAB282 with Oxford University celebrating one year of i..
12/13 EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
12/13 EVOTEC : Enters into Research Collaboration with CRTD to Discover Novel Therapie..
12/13 EVOTEC : enters into research collaboration with CRTD to discover novel therapie..
12/12 CORRECTION OF A RELEASE FROM 11.12.2 : 40 CET/CEST - Evotec AG: Release accordin..
12/11 EVOTEC : Academic Bridge LAB282 with Oxford University Celebrating One Year of I..
12/11 EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
12/11 EVOTEC : S academic bridge lab282 with oxford university celebrating one year of..
12/04 EVOTEC : receives clinical milestone as part of its discovery alliance with Boeh..
12/01 EVOTEC : Receives clinical milestone as part of its discovery alliance with boeh..
More news
News from SeekingAlpha
12/13 Evotec enters into research collaboration with CRTD to discover therapies for..
11/17 Evotec (EVTCY) Presents At Jefferies 2017 London Healthcare Conference - Slid..
11/11 Evotec's (EVOTF) CEO Werner Lanthaler on Q3 2017 Results - Earnings Call Tran..
11/08 MY JOURNEY TO FINANCIAL INDEPENDENCE : 85-Stock October Portfolio Update - Buyin..
11/08 Evotec AG ADR 2017 Q3 - Results - Earnings Call Slides
Financials (€)
Sales 2017 246 M
EBIT 2017 46,2 M
Net income 2017 28,9 M
Debt 2017 103 M
Yield 2017 -
P/E ratio 2017 73,93
P/E ratio 2018 50,75
EV / Sales 2017 9,41x
EV / Sales 2018 7,01x
Capitalization 2 208 M
Chart EVOTEC AG
Duration : Period :
Evotec AG Technical Analysis Chart | EVT | DE0005664809 | 4-Traders
Technical analysis trends EVOTEC AG
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 17,5 €
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Mario Polywka Chief Operating Officer
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC AG74.01%2 611
CELLTRION, INC.--.--%23 699
IQVIA HOLDINGS INC32.70%21 261
INCYTE CORPORATION-3.68%20 703
LONZA GROUP57.44%20 102
ALNYLAM PHARMACEUTICALS, INC.249.60%12 278